跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,171 条关于
“Wells Fargo”
全部
9,171
临床试验
7,547
药物
1,259
机构
14
资讯
351
去年
Intellia Therapeutics Price Target Lowered by Wells Fargo
去年
Wells Fargo Lowers Intellia Therapeutics Price Target to $60
去年
Acelyrin's Izo Fails Phase 2b/3 Trial in Uveitis; Wells Fargo Adjusts Price Target
16天前
NeuroPace to Present RNS System at Cantor and Wells Fargo Healthcare Conferences
上个月
Johnson & Johnson and AbbVie to Present at the 2026 Wells Fargo Healthcare Conference
去年
Promising Phase 1/2 Results for ACELYRIN's Lonigutamab Support Buy Rating
去年
Intellia Therapeutics Announces Strategic Reorganization and 2025 Milestones
去年
Patent Trial and Appeal Board Institutes Review Against Halozyme in Merck Patent Dispute
去年
Alcon's AR-15512 Poised for FDA Approval for Dry Eye Treatment, Analysts Predict
去年
NovoCure's Optune Receives FDA Approval for Expanded Use in Non-Small Cell Lung Cancer
第 1 页,共 36 页
上一页
下一页